NancyEKemenyMD

Oncology • New York, NY

Attending Physician, Memorial Sloan-Kettering Cancer Center

Join to view full profile

Dr. Kemeny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kemeny's full profile

Already have an account?

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1971 - 1974
Rutgers New Jersey Medical SchoolClass of 1971

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License Active through 2025
NY State Medical License 1972 - 2025
VT State Medical License 2022 - 2024
NC State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2002-2014
America's Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Men's Health Castle Connolly, 2007
Fellow (FASCO) American Society of Clinical Oncologists, 2007
Join now to see all

Clinical Trials

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1996 Jan 01
Completed
Phase 3
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 1
Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1998 Sep 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer Start of enrollment: 2000 Aug 01
Completed
Phase 1
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer Start of enrollment: 2003 Jan 01
Active, not recruiting
Phase 1
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer Start of enrollment: 2004 Nov 19
Active, not recruiting
Phase 2
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Start of enrollment: 2007 May 01
Active, not recruiting
Phase 2
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer Start of enrollment: 2000 Aug 01
Completed
Phase 1
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer Start of enrollment: 2011 Mar 01
Active, not recruiting
Phase 2
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Start of enrollment: 2018 Oct 18
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

4 citations
Intraarterial Chemotherapy for Liver Metastases.
Louise C Connell, Nancy E Kemeny
Hematology/oncology Clinics of North America. 2025-02-01
Long term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.
Darren Cowzer, Kevin Soares, Henry Walch, Mithat Gönen, Taryn M Boucher
Journal of the National Cancer Institute. 2024-09-27
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.
Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar
Clinical Cancer Research. 2024-08-15

Journal Articles

Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases
Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Lectures

Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal canc...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Doctors Fret as Firm Stops Making Cancer Drug PumpApril 26th, 2018
Liver-Directed Therapy Shows Improvement in mCRCJanuary 5th, 2018

Grant Support

Therapy Of Hepatic Metastases From Colorectal CarcinomaNational Cancer Institute1993–2001
ST Vincent'S Community Clinical Oncology ProgramNational Cancer Institute1987–1989